Liquidia Stock (NASDAQ:LQDA), Trade Ideas

Liquidia

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

jim-cramer_shutterstock2

AXON

FSLR

LQDA

&#34;Mad Money Lightning Round,&#34; Jim Cramer recommended buying Cloudflare. &#34;I would buy it slowly because we&#39;ve got big selling going on in AI stock Meta,&#34; he added.

Jim Cramer: You&#39;re &#39;Dice Rolling&#39; With This Biopharma Stock, But Vista Energy Is &#39;A Good Situation&#39;

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ABTS

AKLI

ALAB

BTOG

BWMN

CISS

CTAS

CZOO

DNUT

DRCT

DXYZ

FRGE

GMDA

JOAN

LIDR

LIXT

LUXH

LXRX

MESO

MRDB

MRVL

NCNO

NCRA

NOAH

NTRB

NUVB

OTRK

OUST

PAVM

PAYS

RDDT

RVYL

SMTC

SNDA

STKS

VERB

XPEV

Shares of  LuxUrban Hotels Inc.  (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

CYRX

HEAR

HOOD

PERF

PLMR

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday.

Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick&#39;s Sporting Goods And Other Big Stocks Moving Higher On Thursday

Liquidia Corp

Wedbush analyst Seth Basham reiterates Sleep Number (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNBR#NASDAQ">SNBR</a>) with a Neutral and maintains $13.5 price target.

Price Target

Reiteration

Analyst Ratings

SNBR

Wedbush Reiterates Neutral on Sleep Number, Maintains $13.5 Price Target

Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/PI/earnings">financial results on Wednesday</a>.
Impinj posted adjusted earnings of 21 cents per share, beating market estimates of 11 cents per share. The company's quarterly sales came in at $76.83 million versus expectations of $73.57 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
&#8220;2024 started strong, with revenue and profitability exceeding both our fourth-quarter results and first-quarter guidance,&#8221; said Chris Diorio, Impinj co-founder and CEO. &#8220;As we continue driving our bold vision to connect every item in our everyday world, I remain confident in our market position and energized by the opportunities ahead.&#8221;
Impinj said it sees second-quarter non-GAAP EPS of 72 cents to 77 cents and revenue of $96 million to $99 million.
Impinj shares fell 2.2% to close at $120.91 on Wednesday.
These analysts made changes to their price targets on Impinj following earnings announcement.
<ul>
<li>Needham boosted the price target on Impinj from $130 to $160. Needham analyst James Ricchiuti maintained a Buy rating.</li>
<li>Piper Sandler boosted the price target on Impinj from $130 to $150. Piper Sandler analyst Harsh Kumar reiterated an Overweight rating.</li>
</ul>
Now Check This Out: <a href="https://www.benzinga.com/24/04/38429015/jim-cramer-youre-dice-rolling-with-this-biopharma-stock-but-vista-energy-is-a-good-situation">Jim Cramer: You&#8217;re &#8216;Dice Rolling&#8217; With This Biopharma Stock, But Vista Energy Is &#8216;A Good Situation&#8217;</a>

Earnings

Impinj Analysts Boost Their Forecasts After Q1 Results

Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $2.12 by 1.42 percent. This is a 20.37 percent decrease over earnings of $2.70 per share from the same period last year. The company reported quarterly sales of $501.428 million which missed the analyst consensus estimate of $515.992 million by 2.82 percent. This is a 0.72 percent decrease over sales of $505.085 million the same period last year.

Earnings Beats

Earnings Misses

Cullen/Frost Bankers Q1 2024 Adj EPS $2.15 Beats $2.12 Estimate, Sales $501.428M Miss $515.992M Estimate

Investments in Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) have yielded substantial returns for retail investors.
What Happened: Retail investors have seen their investments in Nvidia grow exponentially, Business Insider <a href="https://markets.businessinsider.com/news/stocks/nvidia-stock-retail-investors-gains-generational-wealth-ai-chips-gpus-2024-4">reported</a> based on the review of brokerage and account statements. 
Tom, an Nvidia investor from New Jersey, states that he made an initial investment in the tech giant worth $62,000 in 2011 and 2022. His investments have now ballooned to a $3 million stake. He attributes his success to diligent research and good timing, recognizing Nvidia&#8217;s pivotal role in the development of GPUs.
Nvidia&#8217;s transition from a gaming giant to an AI leader, especially during the early days of the pandemic, has been a significant driver of its stock&#8217;s growth. The company&#8217;s GPUs have become crucial for powering AI programs such as OpenAI&#8217;s ChatGPT, which was launched in November 2022.
See Also: <a href="https://www.benzinga.com/news/24/04/38392548/ups-earnings-show-the-weight-of-170-000-salaries-while-it-learns-to-navigate-shipping-slump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">UPS Earnings Show The Weight Of $170,000 Salaries While It Learns To Navigate Shipping Slump</a>
According to Vanda Research, Nvidia has now overtaken Apple Inc., Tesla Inc., and SPY, the most popular S&amp;P 500 exchange-traded fund, to become the top stock among retail investors.
Other investors, like Danial and Rick, who started investing in Nvidia in 2016 and 2009 respectively, have also seen substantial returns on their investments, despite occasional market downturns.
Why It Matters: In April, Nvidia <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38346847/nvidia-in-correction-territory-did-ai-led-tech-stock-bubble-just-burst-this-data-po">experienced a market sell-off</a> led by high-profile tech stocks, which had been the rally leaders since 2023. Despite the sell-off, CNBC&#8217;s Jim Cramer highlighted Nvidia&#8217;s positive performance and its <a href="https://www.benzinga.com/markets/equities/24/04/38368953/jim-cramer-sees-nvidia-as-going-from-star-of-the-show-to-being-the-goat-of-the-game">4% rise following a 10% drop</a>.
Nvidia&#8217;s powerful chips have attracted <a href="https://www.benzinga.com/news/24/04/38402981/elon-musks-big-bet-tesla-to-ramp-up-ai-development-with-nvidias-powerful-chips">significant customers like Tesla Inc.</a> and <a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber">Meta Platforms Inc.</a>, further bolstering its position in the AI sector. 
Read Next: <a href="https://www.benzinga.com/insights/options/24/04/38361488/palantir-technologies-unusual-options-activity-for-april-22?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Palantir Technologies Unusual Options Activity For April 22</a>
Photo via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Equities

General

AAPL

NVDA

TSLA

Nvidia Investments Shower Retail Investors With Massive Returns Despite Few Cloudy Days: Report

WIIM

Honeywell shares are trading higher after the company reported better-than-expected Q1 financial results.

Leerink Partners analyst Mike Kratky upgrades Tandem Diabetes Care (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) from Market Perform to Outperform and raises the price target from $34 to $45.

Upgrades

TNDM

Leerink Partners Upgrades Tandem Diabetes Care to Outperform, Raises Price Target to $45

On Wednesday,&nbsp;Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) announced its acquisition of Run:ai, an Israeli startup specializing in software that simplifies the management of complex AI workloads and computing resources on a single&nbsp;<a target="_blank" href="https://blogs.nvidia.com/blog/runai/" rel="noreferrer noopener">platform</a>.
Reports indicate a valuation between $600 million &#8211; $700 million. The acquisition marks Nvidia&#8217;s most significant in Israel since its $6.9 billion purchase of Mellanox Technologies Ltd. in 2020, the Times of Israel&nbsp;<a target="_blank" href="https://www.timesofisrael.com/us-chip-giant-nvidia-snaps-up-israeli-ai-workload-management-startup/" rel="noreferrer noopener">reports</a>.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38388117/whats-going-on-with-nvidia-and-amd-stocks-on-tuesday" rel="noreferrer noopener">AMD and Nvidia Recover Losses as AI Market Expansion and New Products Drive Growth</a>
Run: ai&#8217;s team will integrate into Nvidia&#8217;s expansive operations in Israel, which currently employs around 4,000 people across seven R&amp;D centers, including Mellanox&#8217;s headquarters in Yokne&#8217;am, and locations in Tel Aviv, Jerusalem, Ra&#8217;anana, and Beersheba.
Founded in 2018 in Tel Aviv by CEO Omri Geller and CTO Ronen Dar, both postgraduate students under Professor Meir Feder at Tel Aviv University, Run:ai aimed to create a foundational layer for managing any AI workload.&nbsp;
To date, Run:ai&nbsp;has secured $118 million in funding from several investors. Geller noted that Run:ai&nbsp;had already collaborated with Nvidia since 2020.
In a blog post, Alexis Bjorlin, Nvidia&#8217;s VP of DGX Cloud, stated that the acquisition aims to help customers better utilize their AI computing resources.&nbsp;
Bjorlin also mentioned that Nvidia plans to continue selling Run: ai&#8217;s products under the existing business model and invest in the startup&#8217;s product roadmap.
Since establishing its first operations in Israel in 2016 and opening an AI research center in 2018, Nvidia has expanded significantly. The company&#8217;s R&amp;D operations in Israel are now its most significant outside of the U.S.&nbsp;
In March 2022, Nvidia acquired another Israeli company, Excelero, which specializes in enterprise data storage and block storage solutions, for an undisclosed amount.
In May of the previous year, Nvidia revealed that it is developing and building Israel-1, the nation&#8217;s most potent generative AI cloud supercomputer.
Nvidia held $25.98 billion in cash and equivalents as of&nbsp;<a target="_blank" href="https://investor.nvidia.com/news/press-release-details/2024/NVIDIA-Announces-Financial-Results-for-Fourth-Quarter-and-Fiscal-2024/" rel="noreferrer noopener">January 28, 2024</a>.
Thanks to the AI frenzy, Nvidia stock&nbsp;gained 204% in the last 12 months.&nbsp;Investors can gain exposure to the stock via&nbsp;VanEck Semiconductor&nbsp;ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) and&nbsp;Global X&nbsp;Robotics &amp; Artificial Intelligence ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>).
Price Actions:&nbsp;NVDA shares traded lower by 1.84% at $781.59 premarket at&nbsp;the last check on Thursday.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38429949/taiwan-semi-sets-2026-launch-for-a16-chip-technology-aiming-to-outpace-intel-in-speed" rel="noreferrer noopener">Taiwan Semi Sets 2026 Launch for A16 Chip Technology, Aiming to Outpace Intel in Speed</a>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Government

Regulations

Tech

Media

BOTZ

Nvidia Bolsters AI Management Capabilities, Purchases Israeli Firm Run:ai for Roughly $700M

Piper Sandler analyst Luke Lemoine maintains Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) with a Overweight and raises the price target from $180 to $184.

WFRD

Piper Sandler Maintains Overweight on Weatherford International, Raises Price Target to $184

T-Mobile's scalable broadband and wireless growth engine combined with EQT's infrastructure expertise will leverage Lumos' fiber platform to deliver broadband services to more Americans

TMUS

T-Mobile And EQT Announce Joint Venture To Acquire Lumos; T-Mobile Expected To Invest $950M In JV To Acquire 50% Stake And All Existing Fiber Customers; Next Capital Contribution By T-Mobile Out Of Additional Commitment Of ~$500M Anticipated Between 2027-2028

CMCSA

Comcast shares are trading lower following Q1 earnings.

<a href="https://www.globenewswire.com/Tracker?data=d-EZTiuacey9Mg8uAbOVrQ2D5W1ZbPyy47VDaDnv8GABtVzadi-hnwV6Rq2_pOEM7NDDTUvi_14P5fuktECILegFZUG-OMMelEn19X8G-PE=">Quantum&#xAE; Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>), a leading provider of data management solutions for the US Federal Government and Public Sector, and <a href="https://www.globenewswire.com/Tracker?data=NGHmH_P-ChdI7H6-1kWGArcJH5h18hOE4aBXdLVpWfsa_A5FRNPOAp0yrxOkAf1lJZx5mR8nR98ehfOBznQ1drZt1mR2RTSoppe-H1lfbzw=">Carahsoft Technology Corp</a>., The Trusted Government IT Solutions Provider&#xAE;, today announced a partnership. Under the distribution agreement, Carahsoft will serve as a Federal Distributor for Quantum, making the company's cutting-edge end-to-end data solutions available to the Public Sector through Carahsoft's reseller partners and GSA Schedule, NASA Solutions for Enterprise-Wide Procurement (SEWP) V, Information Technology Enterprise Solutions – Software 2 (ITES-SW2), National Association of State Procurement Officials (NASPO) ValuePoint, OMNIA Partners, E&amp;I Cooperative Services Contract and The Quilt contracts. &nbsp;
"We are pleased to partner with Carahsoft and eager to leverage its reseller ecosystem, extensive market reach and established Government expertise to ensure agencies have easy access to our portfolio," said Thomas Hawkes, Vice President of Sales, Americas, Quantum. "We understand the critical role data plays in Government operations and our solutions are designed to support a variety of critical use cases, ranging from geospatial capture and analysis to data forensics and digital data storage. This partnership amplifies our ability to equip Public Sector organizations with the tools and technologies necessary to navigate the complexities of today's data landscape."
Quantum's comprehensive suite of products are designed to meet the Government's unique needs in today's data-intensive landscape. With a focus on scalability, performance and reliability, Quantum's storage solutions empower agencies to efficiently store, manage, retrieve and analyze vast amounts of data, ensuring they stay ahead in a rapidly advancing digital world. Its holistic approach to data lifecycle management includes high-performance flash storage, advanced data protection and archive solutions, creating a diverse portfolio that caters to a variety of Public Sector organizations with tailored solutions that optimize workflows and elevate operational efficiency.
Quantum's AI-driven data platform is built to address user needs at every stage of the data lifecycle, from storage and protection to analysis and enrichment of unstructured data. The platform's advanced AI capabilities enable agencies to efficiently search, tag, catalog and analyze large data sets, helping them discover mission-critical information hidden within data. Public Sector organizations can leverage Quantum's solutions to support better decision-making processes, inform policy choices, enhance national security measures and improve constituent experiences.
"In this unprecedented era of increased unstructured data growth, Quantum's cutting-edge data management solutions enable the Public Sector to keep pace with evolving demands for data storage, protection and analyzation tools that meet the unique needs of Government agencies," said Erin Foor, Sales Director who leads the Quantum Team at Carahsoft. "Carahsoft is excited to partner with Quantum, and we look forward to collaborating with our reseller partners to provide the Public Sector with access to Quantum's holistic portfolio of data-management solutions."
Quantum's software, hardware and services are available through Carahsoft's GSA Schedule No. 47QSWA18D008F, SEWP V contracts NNG15SC03B and NNG15SC27B, ITES-SW2 Contract W52P1J-20-D-0042, NASPO ValuePoint Master Agreement #AR2472, OMNIA Partners Contract #R191902, E&amp;I Contract #EI00063~2021MA and The Quilt Master Service Agreement Number MSA05012019-F. For more information, contact the Carahsoft Team at (571) 591-6220 or <a href="https://www.globenewswire.com/Tracker?data=d-EZTiuacey9Mg8uAbOVrVlT2M1vYYHIRF2fZGeCx_PS-XPfnXXuUfqeH60sSdhaSgsoVJZLzvfz1t_WkaTKDtb0DHuWmdSqc699a1Tvxuo=">Quantum@carahsoft.com</a>; or <a href="https://www.globenewswire.com/Tracker?data=3PipCfFo8siDFORUng_nM1qfqV7cdSO4ma91sXVbpCp8EyltkO_T-k6eIalkWdpbrY4HnHr2t1sp8n9UB2gGHyXJYN9TFFdBwL0yVaQzrxo=">view</a> this on-demand webinar co-hosted by Quantum. The webinar, "Quantum Knows Data - Get to Know Quantum," discusses exciting updates on Quantum's solution set as well as its partner program, <a href="https://www.globenewswire.com/Tracker?data=d-EZTiuacey9Mg8uAbOVrSEUk18uKJBK9mTJxNUPPnWedlvuFwvUuUmdSFAO5yVz8Xiwj9B2m2yhKlMvP8OgY4moMx-qNrRJ8Pm7yWxKhBH3qyGlqFgBDUh5pTdt_XDB">Quantum Alliance</a>.

QMCO

Quantum And Carahsoft Partner To Supply The Public Sector With End-To-End Data Solutions

Tesla Inc. supplier Contemporary Amperex Technology Co. Ltd. (CATL), the world&#8217;s largest electric vehicle battery manufacturer, has unveiled a new battery that can significantly enhance the driving range of electric vehicles (EVs).
What Happened: CATL, at the Auto China show in Beijing, introduced the Shenxing Plus battery pack, which can power a car for up to 600 kilometers (370 miles) on a 10-minute charge, <a href="https://www.bloomberg.com/news/articles/2024-04-25/battery-giant-catl-s-newest-pack-can-power-cars-even-further">reported</a> Bloomberg on Tuesday. The lithium-iron-phosphate battery can provide a range of 1,000 kilometers or over 620 miles on a full charge. Even the Lucid Air sedan, among the highest-range EVs in the market, offers a maximum range of only 516 miles.
This new battery is an upgrade from the Shenxing, which was launched in August. The earlier version could power a vehicle for 400 kilometers from a 10-minute charge or up to 700 kilometers on a full charge. The Shenxing battery is currently used in 50 EV models, including one Xiaomi SU7 variant, the report noted.
Why It Matters: The release of the Shenxing Plus battery is a significant development in the EV industry. It addresses two major concerns that have been <a href="https://www.benzinga.com/general/travel/24/04/38403073/evs-are-great-for-the-environment-and-your-pocket-in-the-long-run-but-here-are-5-surprising-benefi">hindering the widespread adoption of EVs:</a> range anxiety and lack of charging infrastructure. This innovation could potentially accelerate the transition to electric vehicles, especially in China, which is the world&#8217;s largest EV market.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/mobility" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/04/38423295/ford-cfo-says-ev-price-cuts-bringing-down-revenue-faster-than-company-can-cut-costs-if-the-pricing-s">Ford CFO Says EV Price Cuts Bringing Down Revenue Faster Than Company Can Cut Costs; ‘If The Pricing Stabilizes…'</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
CATL Photo by monticello on Shutterstock

Tesla Supplier CATL Unveils New Battery Capable Of Powering EVs For 620 Miles On Full Charge

Newmont shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales.

Barbie and Friends, Hot Wheels Action, and Mattel Jr. to mark Mattel's first-ever FAST channels, enhancing Samsung TV Plus' Family &amp; Kids offering with content featuring iconic Mattel brands
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mattel.com%2F&amp;esheet=53955216&amp;newsitemid=20240425502138&amp;lan=en-US&amp;anchor=Mattel%2C+Inc.&amp;index=1&amp;md5=6512fcf9542edc146bb4def2b63228a4">Mattel, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) has partnered with Samsung to deliver its first three 24/7 Free Ad Supported Streaming (FAST) channels on Samsung TV Plus, Samsung's free TV streaming service. The Barbie and Friends, Hot Wheels Action, and Mattel Jr. channels are set to go live later this year and will be free to access from Samsung Smart TVs, Galaxy Devices and on the Web at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.samsungtvplus.com&amp;esheet=53955216&amp;newsitemid=20240425502138&amp;lan=en-US&amp;anchor=www.samsungtvplus.com&amp;index=2&amp;md5=ff7054061a864b22aa32a222e1e96818">www.samsungtvplus.com</a>. The three new channels from Mattel will feature content inspired by globally beloved brands such as American Girl, Barbie, Hot Wheels, Fisher-Price, Masters of the Universe, Matchbox, classic Monster High, Thomas &amp; Friends, and more.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20240425502138/en/">https://www.businesswire.com/news/home/20240425502138/en/</a>
The Barbie and Friends, Hot Wheels Action, and Mattel Jr. channels are set to go live later this year and will be free to access from Samsung Smart TVs, Galaxy Devices and on the Web at <a href="http://www.samsungtvplus.com/">www.samsungtvplus.com</a>. (Graphic: Business Wire)
With the expanding popularity of FAST streaming services such as Samsung TV Plus, that make premium content available without a subscription, the channels will mark Mattel's first expansion into the growing digital format. The channels will each feature easy to access, around-the-clock kids programming curated for fans of Mattel IP to enjoy hours of shows and family entertainment. The shows will be found on Samsung TV Plus' dedicated ‘Kids' destination on the Samsung TV Plus home screen.
"We always aim to engage our fans in new ways with their favorite Mattel characters and storylines," said Michelle Mendelovitz, Global Head of Mattel Television Studios. "We are pleased to partner with Samsung TV Plus to advance Mattel's content strategy and provide audiences with a premium viewing experience."
"With the global appeal of Mattel's brand portfolio and our expanding content offering, we are thrilled to partner with Samsung TV Plus to establish our first-ever FAST channels," said Jason Horowitz, SVP, Global Head of Marketing &amp; Media at Mattel. "In launching these channels, we gain the opportunity to deepen our relationship with existing Mattel fans and connect with all-new audiences."
Mattel's channel highlights include Barbie and Friends by Mattel, where viewers can join Barbie and her best doll friends as fashion, friendship and thrilling adventures take center stage; Hot Wheels Action by Mattel, featuring heart-pounding races through the world of Hot Wheels, epic battles with He-Man and Skeletor, and charming railway adventures with Thomas &amp; Friends; and Mattel Jr., a child's passport to a world of enchantment, education, and endless fun with Kipper the dog, Pingu the adorable Penguin, and all of Fisher-Price's beloved characters.
"Mattel choosing to launch its first FAST channels with Samsung TV Plus is a testament to the service and audiences we have built," added Sarah Nelson Uberto, Head of Business Development, Partnerships at Samsung TV Plus. "Barbie and Friends, Hot Wheels Action and Mattel Jr. add even more choice to Samsung TV Plus' stable of family-friendly, brand-safe content we know both viewers and advertisers will love."
To learn more about Mattel and Samsung TV Plus, please visit <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.samsungtvplus.com&amp;esheet=53955216&amp;newsitemid=20240425502138&amp;lan=en-US&amp;anchor=www.samsungtvplus.com&amp;index=3&amp;md5=73379730fa439d55184a1880928650da">www.samsungtvplus.com</a>

SSNLF

Mattel Has Partnered With Samsung To Deliver Its First Three 24/7 Free Ad Supported Streaming Channels On Samsung TV Plus

Piper Sandler analyst Alex Twerdahl reiterates Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) with a Overweight and raises the price target from $34 to $38.

Piper Sandler Reiterates Overweight on Bank of N.T Butterfield, Raises Price Target to $38

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Tecogen</h3>
<ul>
<li>The Trade: Tecogen Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGEN#OTC">TGEN</a>) Director Earl R Lewis <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 10,000 shares</a> at an average price of $0.68. To acquire these shares, it cost around $6,800. The company's Director John Hatsopoulos also bought 5,000 shares.</li>
<li>What's Happening: Tecogen is expected to release first-quarter financial results on Thursday, May 9.</li>
<li>What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.</li>
</ul>
<h3 class="wp-block-heading">Bespoke Extracts</h3>
<ul>
<li>The Trade: Bespoke Extracts, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BSPK#OTC">BSPK</a>) CEO Michael Feinsod <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 5,000 shares at</a> an average price of $0.11. To acquire these shares, it cost around $550.</li>
<li>What's Happening: The company's stock lost around 22% over the past six months.</li>
<li>What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.</li>
</ul>
<h3 class="wp-block-heading">GlucoTrack</h3>
<ul>
<li>The Trade: GlucoTrack, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) Director Drew Sycoff <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 182,540 shares</a> at an average price of $1.26. The insider spent around $230,000 to buy those shares.</li>
<li>What's Happening: GlucoTrack recently announced closing of private placement.</li>
<li>What GlucoTrack Does: GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/04/38402061/jim-cramer-says-this-energy-stock-is-terrific-calls-caseys-general-stores-a-winner">Jim Cramer Says This Energy Stock Is &#8216;Terrific,&#8217; Calls Casey&#8217;s General Stores A &#8216;Winner&#8217;</a>

Long Ideas

Insider Trades

Pre-Market Outlook

BSPK

GCTK

TGEN

GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying

As of April 25, 2024, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.  
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Barclays PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCS#NYSE">BCS</a>)</h3>
<ul>
<li>On April 25, Barclays posted a first-quarter GAAP EPS of 52 cents. The company's stock gained around 4% over the past month and has a <a href="https://www.benzinga.com/quote/BCS">52-week high of</a> $9.98.</li>
<li>RSI Value: 70.48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BCS Price Action: Shares of Barclays fell 1% to close at $9.60 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">SLM Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>)</h3>
<ul>
<li>On April 24, SLM posted better-than-expected quarterly earnings. The company's stock gained around 6% over the past five days and <a href="https://www.benzinga.com/quote/SLM">has a 52-week high</a> of $22.21.</li>
<li>RSI Value: 71.88</li>
<li>SLM Price Action: Shares of SLM gained 0.8% to close at $22.10 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>)</h3>
<ul>
<li>On April 19, American Express said first-quarter revenue (net of interest expense) grew 11% year-on-year to $15.80 billion, marginally beating the consensus of $15.79 billion. Chair and CEO Stephen J. Squeri said, "Our fee-based products accounted for around 70 percent of the new account acquisitions we saw in the quarter, and we continue to see strong demand from Millennial and Gen Z consumers, who accounted for over 60 percent of new consumer account acquisitions globally. Our credit metrics remain best in class." The company's stock gained around 10% over the past five days and has a <a href="https://www.benzinga.com/quote/AXP">52-week high</a> of $240.55.</li>
<li>RSI Value: 73.04</li>
<li>AXP Price Action: Shares of American Express gained 0.1% to close at $239.12 on Wednesday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/04/38402061/jim-cramer-says-this-energy-stock-is-terrific-calls-caseys-general-stores-a-winner">Jim Cramer Says This Energy Stock Is &#8216;Terrific,&#8217; Calls Casey&#8217;s General Stores A &#8216;Winner&#8217;</a>

Short Ideas

Top 3 Financial Stocks That Could Sink Your Portfolio This Quarter

Award-winning Developer La Cité and National Homebuilder NVR Ryan Homes Unveil Plans to Address Much-Needed Housing Solutions in Baltimore's Poppleton Development Center\West, Bringing 180 New Homes to the Neighborhood

Contracts

La Cité Development Signs Agreement With NVR Ryan Homes For 180 Units Of Homes

Thursday,&nbsp;AstraZeneca Plc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>)&nbsp;<a target="_blank" href="https://www.astrazeneca.com/media-centre/press-releases/2024/q1-2024-results.html" rel="noreferrer noopener">reported</a>&nbsp;first-quarter sales of $12.68 billion, up 17% year over year (+19% at constant currency), slightly below the consensus of $11.83 billion.&nbsp;
This was fueled by an 18% increase in Product Sales and continued growth in Alliance Revenue from partnered medicines.
The company&#8217;s adjusted EPADS&nbsp;reached $1.03, missing the consensus of $1.22.
Also&nbsp;Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38201849/astrazeneca-hikes-annual-dividend-by-7-just-before-vote-on-its-ceos-pay-package-boost" rel="noreferrer noopener">AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO&#8217;s Pay Package Boost</a>.
R&amp;D expenses rose about 18% to $2.7 billion, while sales, general, and administration costs were up 13% on higher marketing spend for new drug launches.
AstraZeneca&#8217;s top business, oncology, delivered a 26% jump in first-quarter sales to $5.12 billion.
<ul>
<li>Top-selling cancer drugs were Tagrisso and Imfinzi, which generated $1.6 billion and $1.11 billion, up 12% and 29%, respectively.</li>
</ul>
Cardiovascular, Renal, and Metabolism (CVRM) sales increased 20% (up 23 at CER)% to&nbsp;$3.1 billion.
<ul>
<li>Farxiga sales were up 43% (45% at CER) with continued demand growth and the launch of an authorized generic in the U.S., Lokelma was up 16% (19% at CER), roxadustat up 24% (28% at CER), Brilinta decreased 3% (1% at CER).</li>
</ul>
R&amp;I Respiratory &amp; Immunology sales increased 15% (17% CER).
<ul>
<li>Continued strong growth from Fasenra up 6% (6% CER), Breztri up 52% (54% CER).&nbsp;</li>
<li>Saphnelo sales were up 94% (95% CER), and Tezspire was up &gt;2x (&gt;2x CER). Symbicort was up 12% (14% CER).</li>
</ul>
Rare Disease drug sales increased by 12% (+16% at CER) to&nbsp;$2.1 billion.
<ul>
<li>&nbsp;Ultomiris revenues were up 32% (34% at CER), partially offset by a decline in Soliris of 11% (8% at CER)</li>
<li>Strensiq is up 20% (21% at CER), and Koselugo is up 68% (82% at CER), reflecting strong patient demand and tender market order timing.</li>
</ul>
Guidance:&nbsp;For fiscal year 2024, AstraZeneca reaffirms total revenues and core EPS are expected to increase by a low double-digit to low teens percentage at constant exchange rates.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38055367/astrazeneca-ceo-highlights-decade-long-sales-goal-of-45b-along-with-investor-doubts-as-it-lags-in" rel="noreferrer noopener">AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race</a>.
Price Action: At the last check Thursday, AZN shares were up 4.99% at $74.75 during the premarket session.
Photo by Paul McManus via Pixabay

Biotech

Large Cap

Guidance

Health Care

AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance

American Airlines Group Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares are trading higher after the company reported first-quarter financial results and issued second-quarter adjusted EPS guidance&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38426089/american-airlines-reports-first-quarter-2024-financial-results" rel="noreferrer noopener">with a midpoint above estimates</a>.
Total revenue increased 3.1% to $12.57 billion,&nbsp;just&nbsp;missing&nbsp;estimates of $12.60 billion.
Adjusted operating margin stood at 0.6% in the first quarter vs. 3.7% a year ago.
The company reported an adjusted EPS loss of $(0.34), which&nbsp;missed the&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/01/36611285/why-delta-air-lines-shares-are-diving-today" rel="noreferrer noopener">consensus estimate of $(0.29)</a>.
Related:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36803456/american-airlines-is-a-guide-and-beat-story-analyst-says-as-stock-gets-upgrade" rel="noreferrer noopener">American Airlines Is &#8216;A Guide And Beat Story,&#8217; Analyst Says As Stock Gets Upgrade</a>
The company generated an operating cash flow of $2.2 billion and a free cash flow&nbsp;of $1.4 billion in the quarter.
American Airlines reduced its total debt&nbsp;by nearly $950 million in the first quarter and achieved over 80% of its target of reducing debt&nbsp;by $15 billion by the end of 2025.
Guidance:&nbsp;American Airlines expects its second-quarter 2024 adjusted EPS of $1.15&nbsp;&#8211;&nbsp;$1.45,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">versus the consensus of $1.18</a>.&nbsp;
American reiterated its FY24 adjusted EPS outlook of $2.25-$3.25 versus&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/01/36781942/why-is-american-airlines-stock-flying-higher-today" rel="noreferrer noopener">the consensus of $2.35</a>.
The company&nbsp;<a target="_blank" href="https://americanairlines.gcs-web.com/static-files/ee8874a2-7121-48c3-aa61-c2927095863f" rel="noreferrer noopener">expects</a>&nbsp;its second-quarter 2024 capacity to be up 7%-9%, with full-year capacity&nbsp;to be&nbsp;up mid-single digits Y/Y.
The second-quarter total revenue per available seat mile (TRASM)&nbsp;is expected&nbsp;to be down approximately 1%-3% Y/Y.
The company expects its second-quarter cost per available seat mile (CASM-ex), excluding fuel, to be up approximately 1% to 3% Y/Y, with its full-year CASM-ex up approximately 0.5% to 3.5% Y/Y.
Robert Isom, CEO, said, &#8220;While we aren&#8217;t satisfied with our first-quarter financial results, we have a strong foundation in place, and we remain on track to deliver on our full-year financial targets. Our team is running a fantastic operation, driving revenue through our commercial initiatives, efficiently managing costs, and producing free cash flow&nbsp;to&nbsp;further&nbsp;strengthen our balance sheet.&#8221;
In March, American Airlines placed orders for 260 new aircraft, including Airbus A321neo, Boeing 737 MAX 10,&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37463518/american-airlines-shares-are-declining-today-whats-going-on" rel="noreferrer noopener">and Embraer E175 models</a>.
Investors can gain exposure to the stock via&nbsp;U.S. Global Jets ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JETS#NYSE">JETS</a>) and&nbsp;Themes Airlines ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRL#NASDAQ">AIRL</a>).
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38253927/american-airlines-pilots-warn-amid-safety-concerns-surge-report" rel="noreferrer noopener">American Airlines Pilots Warn Amid Safety Concerns Surge: Report</a>
Price Action: AAL shares are up 3.45% at $14.40 premarket at the last check Thursday.
Photo via Shutterstock

AIRL

JETS

Why Is American Airlines Stock Seeing Blue Skies Today?

Liquidia Technologies (LQDA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein fr...

Buy Rating Affirmed for Liquidia Technologies with Doubling Price Target on Yutrepia's Promising Prospects

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Liquidia Technologies (LQDA – Research Report) and L...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Legend Biotech (LEGN)

Analyst Andreas Argyrides of Wedbush reiterated a Sell rating on Liquidia Technologies (LQDA – Research Report), with a price target of $3.00. Andr...

Liquidia Technologies Faces Sell Rating Amid Legal Struggles and Market Competition

A rating of 96 puts Liquidia Corp (LQDA) near the top of the Biotechnology industry according to InvestorsObserver. Liquidia Corp's score of 96 means it scores higher than 96% of stocks in the industry. Liquidia Corp also received an overall rating of 80, putting it above 80% of all stocks. Biotechnology is ranked 18 out o

Is Liquidia Corp (LQDA) a Smart Choice in Biotechnology Thursday?

Liquidia gains after court win in patent dispute with United Therapeutics

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied

Liquidia Corp (LQDA) is up 10.85% today. LQDA has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on LQDA!See Full LQDA ReportLQDA stock closed at $14.75 and is up $1.60 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investo

Should You Sell Liquidia Corp (LQDA) Stock Monday Morning?

Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) today and set a price target of $28.00. Se...

Buy Rating Justified by Favorable Legal Outcomes and Imminent FDA Decision for Liquidia Technologies' Yutrepia

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT – Research Report), Liquidia Technol...

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)

Analyst Serge Belanger from Needham maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) and keeping the price target at $28.0...

Buy Rating for Liquidia Technologies: Innovation and Market Potential Drive Strong Investment Case

LEGN

RCKT

UTHR

XTNT

Financing

Press Releases

Liquidia Corporation Announces $100 Million in New Financings

Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

Legal

Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

Management

Liquidia Corporation Announces Updates to Operations Leadership

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference